Takashi Kei Kishimoto (Takashi K Kishimoto)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Walled Carbon Nanotubes

Top Venues

Science advances

Nature communications

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Petr O Ilyinskii, Christopher Roy, Alicia M Michaud, Gina Rizzo, Teresa Capela, Sheldon S Leung, Takashi Kei Kishimoto
Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents. PNAS nexus 2 (11) (2023)
Takashi Kei Kishimoto, Richard Jude Samulski
Addressing high dose AAV toxicity - 'one and done' or 'slower and lower'? Expert opinion on biological therapy 22 (9) (2022)
Earl Sands, Alan Kivitz, Wesley DeHaan, Sheldon S Leung, Lloyd Johnston, Takashi Kei Kishimoto
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia. Nature communications 13 (1) (2022)
Petr O Ilyinskii, Alicia M Michaud, Christopher J Roy, Gina L Rizzo, Stephanie L Elkins, Teresa Capela, Aparajita C Chowdhury, Sheldon S Leung, Takashi Kei Kishimoto
Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles. Science advances 7 (9) (2021)